Home
Conditions
Pharyngeal Diseases

Clinical trial condition

Pharyngeal Diseases

Explore clinical trials studying Pharyngeal Diseases. Study availability and eligibility vary by location and protocol.

1,560 public trials 361 recruiting studies

Refine in advanced search Browse all conditions

Pharyngeal Diseases trial results

Active, Not Recruiting

Trial of Individualized Adaptive RT in HPV-related High Risk Oropharynx Cancer

NCT06234748

Conditions: HPV-Related Carcinoma, Head and Neck Neoplasms, Neoplasms, +8 more
Locations: University of Michigan Rogel Cancer Center Ann Arbor, Michigan, United States

View Trial Details

Active, Not Recruiting

Testing the Addition of an Anti-cancer Drug, Ipatasertib, to the Usual Immunotherapy Treatment (Pembrolizumab) in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck

NCT05172258

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +32 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

City of Hope at Irvine Lennar Irvine, California, United States

City of Hope Antelope Valley Lancaster, California, United States

Keck Medicine of USC Koreatown Los Angeles, California, United States

View all 20 locations

View Trial Details

Active, Not Recruiting

Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal Carcinoma

NCT05780372

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +12 more
Locations: Chongqing Cancer Hospital Chongqing, Chongqing Municipality, China

Dongguan People Hospital Dongguan, Guangdong, China

Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

Liuzhou Worker's Hospital Liuzhou, Guangxi, China

View Trial Details

Active, Not Recruiting

Programmed Death-1 (PD-1) Antibody Combined With Chemoradiotherapy in High-risk Recurrent Nasopharyngeal Carcinoma

NCT03930498

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +12 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine in the Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma

NCT05294172

Conditions: Carcinoma, Disease Attributes, Head and Neck Neoplasms, +18 more
Locations: Cancer Hospital Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

View Trial Details

Active, Not Recruiting

INBRX-106 in Combination With Pembrolizumab in First-line PD-L1 CPS≥20 HNSCC

NCT06295731

Conditions: Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +19 more
Locations: City of Hope Medical Center Duarte, California, United States

Los Angeles Cancer Network (LACN) Los Angeles, California, United States

UC Davis Sacramento, California, United States

Medical Oncology Associates of San Diego San Diego, California, United States

View all 87 locations

View Trial Details

Active, Not Recruiting

Adjuvant Sintilimab Plus Capecitabine in Nasopharyngeal Carcinoma

NCT05201859

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

CompARE: Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer (OPC)

NCT04116047

Conditions: Head and Neck Neoplasms, Neoplasms, Neoplasms by Site, +7 more
Locations: St Luke's Hospital Dublin, Ireland

St James's Hospital Dublin, Ireland

Aberdeen Royal Infirmary Aberdeen, United Kingdom

Bristol Haematology and Oncology Centre Bristol, United Kingdom

View all 38 locations

View Trial Details

Active, Not Recruiting

SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal Carcinoma

NCT05524168

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +11 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Active, Not Recruiting

Compression Therapy as a Prophylactic Method Against CIPN: a Prospective Self-controlled Trial

NCT05531916

Conditions: CIPN - Chemotherapy-Induced Peripheral Neuropathy, Carcinoma, Head and Neck Neoplasms, +12 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Pharyngeal Diseases

Pharyngeal Diseases trial results

Related conditions